Bloomberg
Prior to Trump’s pharma tariff and H-1B visa fee shocks, the MSCI India gauge had risen for three straight weeks, adding more than 4% in what was its longest run since May
Read More
Trump’s dual shocks thwart bets on Indian stock market rebound
Bloomberg
14:20
Prior to Trump’s pharma tariff and H-1B visa fee shocks, the MSCI India gauge had risen for three straight weeks, adding more than 4% in what was its longest run since May
